News | News By Subject | News by Disease News By Date | Search News

Bleeding News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Why Rigel (RIGL)'s Layoffs May Not be a Bad Thing     9/19/2016
Bay Area's Rigel (RIGL) Slashes 38% of Workforce; Shifts From R&D to Commercial Operation     9/16/2016
Rigel (RIGL)'s Bleeding Disorder Drug Passes First of Two Key Late-Stage Trials     8/30/2016
Defective Device Forces Regulators to Take a Hard Look at Bayer (BAY)'s Xarelto Trial     12/9/2015
FDA Gives Nod to Baxalta (BXLT)'s Rare Bleeding Disorder Drug Vonvendi     12/9/2015
Baxter International (BAX)'s Bleeding Disorder Drug Delivers 100% Success Rate in Late-Stage Study     4/21/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Boehringer Ingelheim Corporation Says New Bleeding Cases Found In Pradaxa Study     5/15/2014
Alnylam Pharmaceuticals (ALNY) Reports Initial Positive Top-Line Data From Phase 1 Clinical Trial With ALN-AT3, An RNAi Therapeutic Targeting Antithrombin (AT) In Development For The Treatment Of Hemophilia And Rare Bleeding Disorders (RBD)     5/13/2014
FDA: Boehringer Ingelheim Corporation's Pradaxa Benefit Outweighs Bleeding Risk     12/8/2011
Novo Nordisk A/S (NVO) Bleeding Drug May Harm Hospital Trauma Patients, Study Says     4/19/2011
FDA Approves Exelixis, Inc. (EXEL) Product to Prevent Bleeding in People With Rare Genetic Defect     2/18/2011
Merck & Co., Inc. (MRK) Says Clot Preventer has Bleeding Risk     1/20/2011

News from Around the Web
New Device Could Quickly Assess Brain Bleeding In Head Injuries, Academic Emergency Medicine Reveals     4/6/2017
Why Ionis Pharma (IONS)'s Extensive And Deep Pipeline Could Get Investors' Hearts Pumping     3/8/2017
A New Hydrogel Made From Snake Venom Stops Bleeding In Seconds, Rice University Reveals     10/27/2015
Denying Vitamin K Puts Infants At Risk For Rare Bleeding Disorders, Centers for Disease Control and Prevention (CDC) Reports     11/15/2013
American Society of Hematology: No Excess Bleeding With Apixaban in Hip, Knee Trial, University of Oklahoma Study     12/6/2010
Blood Thinning Drug Warfarin Linked To Increased Bleeding In Brain, University of Cincinnati Study     9/30/2008
Antidepressants Tied To Gastrointestinal Bleeding, Spanish Agency for Medicines and Healthcare Products Study     7/8/2008
Coagulation Factor VIIa Provides Less Hemorrhaging After Stroke, But Not Fewer Deaths, University of Heidelberg Study     6/11/2008
Genetic Test Predicts Response to Warfarin     3/6/2008
Anti-Clotting Drug Trial Shortened by Bleeding Problems     1/25/2008
Asians Prone to Bleeding with Anti-Clotting Drugs     9/13/2007
Clinical Trial On Dysfunctional Uterine Bleeding (DUB) Now Conducted By Thomas L. Lyons, MD, GYN Surgeon     7/31/2007
African Plant Halts Bleeding, Speeds Healing     7/27/2007
Gel Made from Patient's Blood Speeds Healing, University of Cincinnati Medical Center Study Finds     5/22/2007
Patients with "Bleeding" Strokes Less Likely to Get Prevention Treatment     5/11/2007

Press Releases
Janssen R&D Submits Supplemental New Drug Application To U.S. FDA Based On EINSTEIN CHOICE Data, Which Showed Superiority With XARELTO (Rivaroxaban) Versus Aspirin In Reducing Risk Of Recurrent Venous Thromboembolism (VTE), With Low Rates Of Major Bleeding Across Groups     5/1/2017
New Device Could Quickly Assess Brain Bleeding In Head Injuries, Academic Emergency Medicine Reveals     4/6/2017
Edge Therapeutics Announces First Patient Randomized In Study Of Intracisternal Administration Of EG-1962 In Adults With Aneurysmal Subarachnoid Hemorrhage     3/13/2017
Real-World Data From Boehringer Ingelheim Show Lower Risk Of Stroke And Major Bleeding For Pradaxa (Dabigatran Etexilate Mesylate) Compared To Warfarin     2/24/2017
Alnylam (ALNY) Presents Updated Results From Phase I/II Study Of ALN-CC5 In Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)     12/5/2016
Shire (SHPG) Release: Topline Results Of Phase 3 Investigational Study Of VONVENDI [Von Willebrand Factor (Recombinant)] Meets Primary Endpoint Effectively Controlling Bleeding And Blood Loss During Surgical Procedures     12/2/2016
Portola (PTLA) Announces Andexxa™ (Andexanet Alfa), Betrixaban And Cerdulatinib Data To Be Presented At 2016 American Society of Hematology Annual Meeting And Exposition     11/28/2016
Portola (PTLA) Announces Three Phase III APEX Substudy Results Showing Further Benefits Of Treating Acute Medically Ill Patients With Extended-Duration Betrixaban     11/15/2016
Baxter International (BAX) Initiates Clinical Trial For Citrate Anticoagulant For Use During Continuous Renal Replacement Therapy     11/2/2016
Portola (PTLA) Submits New Drug Application To FDA For Betrixaban For Extended Duration Prophylaxis Of Venous Thromboembolism In Acute Medically Ill Patients     10/25/2016
Viveve Snags FDA Nod for the Viveve System in the U.S.     10/7/2016
Johnson & Johnson (JNJ) Allegedly Failed to Disclose Faulty Device Concerns in Xarelto Trial     9/30/2016
Portola (PTLA) Announces Upcoming Data Presentations On Andexxa (Andexanet Alfa) At Neurocritical Care Society 2016 Annual Meeting     9/13/2016
Edge Therapeutics Announces Additional Pharmacokinetic Data Supporting The Potential Clinical And Health Economic Impact Of EG-1962 In Aneurysmal Subarachnoid Hemorrhage     9/7/2016
Portola (PTLA) Announces Interim Results From Ongoing Phase IIIb/IV ANNEXXA-4 Study Of Factor Xa Inhibitor Antidote Andexxa (Andexanet Alfa) In Patients With Acute Major Bleeding     8/30/2016

//-->